We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Growth in Overseas Device Trials Fuels FDA Draft Guidance
Growth in Overseas Device Trials Fuels FDA Draft Guidance
The FDA is advising devicemakers that plan to support a premarket submission with data from clinical studies conducted outside the U.S. to meet with the agency before finalizing their trial designs.